Metraipolis › archive › dc_7a8ff1a4b673
Age at onset distinguishes clinical features and relapse risk in autoimmune glial fibrillary acidic protein astrocytopathy — Europe PMC PMID:42292477
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42292477
- DOI
- 10.3389/fimmu.2026.1856124
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T05:04:07.534Z
- SHA-256 of the archived text
92730ef51487f45dd0195ab33b4050ffeefb195e782c176cebbb9893fece79f2- Stable URL of this page
https://metraipolis.com/documento/dc_7a8ff1a4b673
How to cite
Age at onset distinguishes clinical features and relapse risk in autoimmune glial fibrillary acidic protein astrocytopathy — Europe PMC PMID:42292477 — Europe PMC (en), https://europepmc.org/article/MED/42292477 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7a8ff1a4b673 (Metraipolis archive dc_7a8ff1a4b673, sha256 92730ef51487f45dd0195ab33b4050ffeefb195e782c176cebbb9893fece79f2)
BibTeX
@misc{dc7a8ff1a4b673,
title = {Age at onset distinguishes clinical features and relapse risk in autoimmune glial fibrillary acidic protein astrocytopathy — Europe PMC PMID:42292477},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42292477},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7a8ff1a4b673; sha256 92730ef51487f45dd0195ab33b4050ffeefb195e782c176cebbb9893fece79f2},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42292477. Agents can read the archived copy with the MCP tool read_document.